 |
Heterologous Antibodies Form
Infectious Complexes
| In this depiction of the second step in antibody-dependent
enhancement, dengue type B represents the new serotype. The
anti-A antibodies produced in response to the original infection
can form complexes with the new serotype, as we see here. However,
the new virus serotype is not neutralized by these heterologous
antibodies. The virus retains its capacity to become active
and replicate. |
|
|
|
